I propose to take Questions Nos. 12, 35, 37 and 38 together.
Up to end November 1997, 70 cases of BSE were detected in Ireland compared to 62 cases during the same period last year. By way of comparison, the number of cases confirmed for the period July-November 1997 was 33 compared with 49 for the same period in 1996. In addition, the number of cases in November 1997 was five compared to 18 during the same month in 1996. I have already outlined on previous occasions the stringent controls which are in place in Ireland to ensure the safety of Irish beef which go beyond those recommended by the relevant international organisations. These include the depopulation of herds in which a case of BSE is confirmed and the removal of specified risk material from all carcases after slaughter. This risk material is then disposed of under strict conditions.
The Enfer test referred to is a commercial test involving a post-mortem diagnostic method for detecting BSE and is based on the measurement of the disease specific prion protein. It employs an ELISA protocol and its unique feature is a novel method of binding the prion protein to the surface of an ELISA plate. The veterinary research laboratory of my Department participated in the validation of the test and the results obtained showed excellent discrimination between negatives and positives. The major advantages of the rest are that it can give a much more rapid result than the existing histopathological and immunohistochemical methods and it has the potential to be fully automated. I understand that the company concerned is currently gearing up to providing the test on a commercial basis. The cost of the test will be a commercial decision for the company itself.
This test and some others that are being validated elsewhere have the potential to make a positive contribution to providing additional reassurance as to the safety of beef. The question as to whether the test will provide any additional benefits to the beef industry in its commercial dealings is primarily a matter for the industry itself. At this stage, I do not have any plans to introduce the test on a compulsory basis over and above those controls already in place in Ireland as far as BSE is concerned. I will, however, keep the position under review.